PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe
Go back to PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe| (NASDAQ: PDSB) | Delayed: 1.11 -0.05 (4.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.16 | 52 Week High | $ | |||
| Open | $1.11 | 52 Week Low | $ | |||
| Day High | $1.13 | P/E | N/A | |||
| Day Low | $1.06 | EPS | $ | |||
| Volume | 2,703,981 | |||||



